Clinical Trial Update: ASO Treatment for Syndromic Craniosynostoses

View source ↗

Summary

A clinical trial update for an antisense oligonucleotide (ASO) treatment targeting syndromic craniosynostoses, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apert Syndrome
• Craniosynostosis
• Crouzon Syndrome
• Muenke Syndrome
• Pfeiffer Syndrome
• Saethre-chotzen Syndrome

Drugs mentioned

• ASO Treatment for Syndromic Craniosynostoses

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Craniosynostoses, Crouzon Syndrome | Status: NOT_YET_RECRUITING